Upstaging of patients diagnosed with favorable intermediate-risk prostate cancer – is AS really a suitable approach for all these patients?

Introduction: Current NCCN and EAU guidelines define a subgroup of favorable intermediate-risk (FIR) ISUP grade group (GG) 2 prostate cancer (PCa), in which active surveillance (AS) can be considered a suitable course of action. Defined per NCCN guidelines, these patients may be diagnosed with up to [for full text, please go to the a.m. URL]